Who founded Genome Square?

Genome Square was founded by Paul Mullan, James Beirne, Laura Feeney.

Who are Genome Square's investors?

Genome Square's investors include Clarendon Fund Managers Ltd..

Where is Genome Square headquartered?

Genome Square is headquartered in UK, GB.

Genome Square

UK, GB · 1 known investors

Find your way into Genome Square

Paths you didn't know you had: your email and LinkedIn already hold routes to the Genome Square team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

GenoME Diagnostics develops PCR-based diagnostic and biomarker technologies for cancer, with research programmes in ovarian and pancreatic cancer. The company builds on cancer biomarker and DNA methylation research from its academic founders.

AI & Machine Learning Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Paul MullanCo-Founder and Professor of Oncology

James BeirneCo-Founder

Laura FeeneyCo-Founder

Investors · 1

Clarendon Fund Managers Ltd.listed by Clarendon Fund Managers Ltd.Belfast · $63K – $3.8M

How we know: Clarendon Fund Managers Ltd.'s portfolio page · Not right? Tell us

Frequently asked questions

What does Genome Square do?: GenoME Diagnostics develops PCR-based diagnostic and biomarker technologies for cancer, with research programmes in ovarian and pancreatic cancer. The company builds on cancer biomarker and DNA methylation research from its academic founders.
Who founded Genome Square?: Genome Square was founded by Paul Mullan, James Beirne, Laura Feeney.
Who are Genome Square's investors?: Genome Square's investors include Clarendon Fund Managers Ltd..
Where is Genome Square headquartered?: Genome Square is headquartered in UK, GB.